CHARLESTON, S.C., Aug. 24, 2010 (GLOBE NEWSWIRE) -- Since Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCBB:RMCP) acknowledged the successful completion of its Pilot Run for our new manufacturing design changes to our RevVac Safety Syringe earlier in May, the company has been working closely with a U.S. manufacturer to complete market samples. These new samples sport the company's new label, have only eight parts compared to twelve, have even better performance, and are less expensive to mass manufacture. With the completion of market samples, Revolutions Medical can now finalize negotiations with manufacturers, distributors and begin announcing preliminary sales orders over the coming weeks. As countries all over the world continue to put forward legislation for the committed use of safety syringes, timing could not be better.
"Not only do I think we have the world's least expensive and best automatic retractable safety syringe, our manufacturing price could even be competitive with standard high quality syringes over time. With the many advantages of our safety syringe; reducing accidental needle stick injuries, reducing the spread of blood borne pathogens, and the savings on sharp's hazardous disposal, I feel we have an actual replacement of the standard syringe that has been used in the medical workplace for decades," states Ron Wheet, CEO, Revolutions Medical Corporation.
About Revolutions Medical Corporation
Revolutions Medical is a safety medical device and software application company. Its products include the RevVac safety syringe (FDA approved), safety blood drawing device and safety IV catheter. The Company also provides RevColor, RevDisplay and Rev3D -- software solutions and proprietary tools that are compatible with standard MRIs and standard PACS. The software suite's functionality includes sorting of images, color, 3D and automatic segmentation of images.
For additional information, please visit Revolutions Medical corporate website: www.revolutionsmedical.com/" target="_top" rel="nofollow">http://www.revolutionsmedical.com.
Investor Resource Center
Fact Sheet:
http://content.stockpr.com/rmcp/files/RMCP+-+Fact+Sheet+02-26-10.pdf
CEO Ron Wheet Audio Interview:
http://ir.stockpr.com/revolutionsmedical/media-center/view/33/
RevVac Safety Syringe Demonstration Video:
http://revolutionsmedical.com/
RevColor MRI Video:
www.revolutionsmedical.com/RevMed-ColorMRI-Video.php" target="_top" rel="nofollow">http://www.revolutionsmedical.com/RevMed-ColorMRI-Video.php
To be added to the Revolutions Medical investor email list, please email www.globenewswire.com/newsroom/ctr%3Fd=191624%26l=13%26a=Skey%2540revolutionsmedical.com%26u=mailto%253ASkey%2540revolutionsmedical.com">Skey@revolutionsmedical.com with RMCP in the subject line.
Become a RevMed fan and follow the Company on Facebook -- visit www.Facebook.com/Revmed" target="_top" rel="nofollow">http://www.Facebook.com/Revmed
FORWARD-LOOKING STATEMENTS
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.